Lubguban, Lourdes P.
HRN: 25-97-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2024
CEFTRIAXONE 1G (VIAL)
09/28/2024
10/12/2024
IVT
2g
OD
Typhoid
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes